Connection

Armand Glassman to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Back to Details
This is a "connection" page, showing publications Armand Glassman has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Armand Glassman
Connection Strength
1.166
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  1. Determination of secondary chromosomal aberrations of chronic myelocytic leukemia. Cancer Genet Cytogenet. 2004 Aug; 153(1):53-6.
    View in: PubMed
    Score: 0.234
  2. A unique, complex variant philadelphia chromosome translocation in a patient with typical chronic myelogenous leukemia. Arch Pathol Lab Med. 2001 Mar; 125(3):437-9.
    View in: PubMed
    Score: 0.185
  3. Detection of trisomy 8 in philadelphia chromosome-positive CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques and its relation to c-myc involvement. Ann Clin Lab Sci. 2001 Jan; 31(1):68-74.
    View in: PubMed
    Score: 0.182
  4. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases. Am J Clin Pathol. 2005 Nov; 124(5):807-14.
    View in: PubMed
    Score: 0.064
  5. Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia. Blood. 2005 Mar 15; 105(6):2281-6.
    View in: PubMed
    Score: 0.060
  6. t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia. Am J Clin Pathol. 2004 Jun; 121(6):836-42.
    View in: PubMed
    Score: 0.058
  7. Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome. Br J Haematol. 2004 Apr; 125(2):187-95.
    View in: PubMed
    Score: 0.057
  8. Quantitative measurement of BCR/abl transcripts using real-time polymerase chain reaction. Ann Oncol. 2002 May; 13(5):781-8.
    View in: PubMed
    Score: 0.050
  9. Translocation t(17;18)(q10;q10): a new nonrandom chromosomal translocation of clonal evolution in chronic myeloid leukemia. Cancer. 2001 May 01; 91(9):1704-8.
    View in: PubMed
    Score: 0.047
  10. Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia. J Clin Oncol. 2000 May; 18(9):1831-6.
    View in: PubMed
    Score: 0.044
  11. Cytogenetics, in situ hybridization and molecular approaches in the diagnosis of cancer. Ann Clin Lab Sci. 1998 Nov-Dec; 28(6):324-30.
    View in: PubMed
    Score: 0.039
  12. Philadelphia chromosome-positive myeloid cells in the peripheral blood of chronic myelogenous leukemia patients: comparison with the frequency detected in cycling cells of the bone marrow. Clin Cancer Res. 1998 Apr; 4(4):861-7.
    View in: PubMed
    Score: 0.038
  13. Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia. Bone Marrow Transplant. 1997 Mar; 19(6):565-70.
    View in: PubMed
    Score: 0.035
  14. Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients. Am J Clin Pathol. 1996 Oct; 106(4):442-8.
    View in: PubMed
    Score: 0.034
  15. Cytogenetics, gene fusions, and cancer. Ann Clin Lab Sci. 1995 Sep-Oct; 25(5):389-93.
    View in: PubMed
    Score: 0.032
  16. Applicability of direct in situ reverse transcription-polymerase chain reaction on bone marrow smears. Ann Clin Lab Sci. 1998 Jan-Feb; 28(1):34-42.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.